SuriyaAJeyapalanMDMPH

Neurology • Boston, MA

Neurooncology

Assistant Professor, Neurology, Tufts University

Join to view full profile

Dr. Jeyapalan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jeyapalan's full profile

Already have an account?

Office
330 Brookline Ave
Tcc867
Boston, MA 02215
Phone+1 617-667-9898

Fax+1 617-636-8538

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1996 - 1999
University of Iowa Hospitals and ClinicsInternship, Internal Medicine, 1995 - 1996
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1995

Certifications & Licensure

CA State Medical License 2003 - Present
MA State Medical License 1999 - 2025
RI State Medical License 2009 - 2016
IA State Medical License 1995 - 1997
American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

320 citations
Acute and Chronic Graft-Versus-Host Disease After Allogeneic Peripheral-Blood Stem-Cell and Bone Marrow Transplantation: A Meta-Analysis
Corey Cutler, Satyendra Giri, Suriya Jeyapalan, David Paniagua, Akila N. Viswanathan
Journal of Clinical Oncology. 2001-08-15
44 citations
Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database
Takahisa Mikami, Bobby Chi-Hung Liaw, Mizuho Asada, Takahiro Niimura, Yoshito Zamami
Journal of Neuro-Oncology. 2021-01-09
28 citations
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, effic...
Priya U Kumthekar, Michael J Avram, Andrew B Lassman, Nancy U Lin, Eudocia Lee
Neuro-Oncology. 2023-03-14

Lectures

Analysis of the EF-14 phase III trial reveals that tumor treating fields alter progression patterns in glioblastoma.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Dad, 51, Thought Seizures Were from ‘Too Much Coffee’ – but He Had a Brain Cancer: Know the SignsMay 14th, 2023